Mir-153-3p Modulates the Breast Cancer Cells’ Chemosensitivity to Doxorubicin by Targeting KIF20A
Open Access
Abstract
Breast cancer is considered the solid tumor most sensitive to chemotherapy. However, it can become resistant to various chemotherapeutic drugs, including doxorubicin, which triggers cell death by intercalation between DNA bases, free radical formation, and topoisomerase II inhibition. When drug resistance develops, several miRNAs are dysregulated, suggesting that miRNAs may play a significant role in resistance formation. In the current study, we investigated how doxorubicin sensitivity of breast cancer cells is affected by miR-153-3p and its target gene. The MTT method was used to determine the chemo-sensitizing effect of miR-153-3p on doxorubicin in MCF-7 and MDA-MB-231 cell lines. Results of Western blot and dual luciferase confirmed that miR-153-3p targets KIF20A and decreases its expression. Transwell and flow cytometry experiments showed that miR-153-3p and doxorubicin together had higher effects on MCF-7 and MDA-MB-231 cell proliferation, migration, and invasion, as well as increasing apoptosis and arresting cells in the G1 phase. Proteins related to apoptosis and the cell cycle exhibited the same tendency. Intracellular vesicle formation was inhibited and RAB26 was also downregulated by treatment with miR-153-3p alone or in combination with doxorubicin. Doxorubicin’s ability to suppress tumors may be enhanced by miR-153-3p, according to in vivo studies. According to our findings, miR-153-3p has a direct effect on KIF20A and may regulate the formation of intracellular vesicles, which in turn makes breast cancer cells more susceptible to doxorubicin.Keywords
Funding Information
- National Natural Science Foundation of China (81371676)
This publication has 44 references indexed in Scilit:
- Reversal of doxorubicin resistance in breast cancer by mitochondria-targeted pH-responsive micellesActa Biomaterialia, 2015
- The GTPase Rab26 links synaptic vesicles to the autophagy pathwayeLife, 2015
- Human Epidermal Growth Factor Receptor 2 (HER2) in Cancers: Overexpression and Therapeutic ImplicationsMolecular Biology International, 2014
- Suppression of AKT expression by mi R ‐153 produced anti‐tumor activity in lung cancerInternational Journal of Cancer, 2014
- RAB26 coordinates lysosome traffic and mitochondrial localizationJournal of Cell Science, 2014
- Genome-wide reprogramming of the chromatin landscape underlies endocrine therapy resistance in breast cancerProceedings of the National Academy of Sciences, 2013
- Novel Interactions between FOXM1 and CDC25A Regulate the Cell CyclePLOS ONE, 2012
- Chemotherapy-Resistant Metastatic Breast CancerCurrent Treatment Options in Oncology, 2012
- Alterations of microRNAs and their targets are associated with acquired resistance of MCF‐7 breast cancer cells to cisplatinInternational Journal of Cancer, 2010
- Detection of lung, breast, colorectal, and prostate cancers from exhaled breath using a single array of nanosensorsBritish Journal of Cancer, 2010